Vimarsana
Biggest News Aggregation in the World

Prokidney Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prokidney Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prokidney Corp Today - Breaking & Trending Today

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering - Vimarsana News

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

WINSTON-SALEM, N.C., June 11, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an...

Ross commits to $450-million, 852-job project in Randleman - Vimarsana News

Ross commits to $450-million, 852-job project in Randleman

The company's ninth distribution center, with warehousing, fulfillment and packing operations, will be a 1.7 million square-foot facility on 330 acres.

ProKidney (NASDAQ:PROK) Trading Up 4.7% - Vimarsana News

ProKidney (NASDAQ:PROK) Trading Up 4.7%

ProKidney Corp. (NASDAQ:PROK – Get Free Report) shares were up 4.7% during trading on Tuesday . The stock traded as high as $3.62 and last traded at $3.53. Approximately 29,186 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 688,385 shares. The stock had previously closed at $3.37. […]

Source: wkrb13.com
Ross commits to $450-million, 852-job project in Randleman - Vimarsana News

Ross commits to $450-million, 852-job project in Randleman

The company's ninth distribution center, with warehousing, fulfillment and packing operations, will be a 1.7 million square-foot facility on 330 acres.

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 - Vimarsana News

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

WINSTON-SALEM, N.C., May 21, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , will host a virtual KOL event on Tuesday, May...